Autoantibodies in the Grocery Shop: Does Quantity Matter?

Overview

Journal Immunol Res

Specialty Allergy & Immunology

Date 2013 Apr 11

PMID 23572431

Citations 4

Authors

Jan Damoiseaux

Affiliations

Soon will be listed here.

Abstract

Testing for autoantibodies is an integrated part in the diagnostic process of many autoimmune diseases. As a consequence, the detection of autoantibodies is increasingly recognized in classification criteria and diagnostic guidelines. In this review, the question is addressed whether quantification of autoantibodies is clinically useful, not only in the diagnostic stage, but also during follow-up of patients with autoimmune diseases. It can be concluded that for a multitude of autoantibodies, there is sufficient evidence that the higher the amount of autoantibodies, the more likely that the patient has the respective autoimmune disease. Quantification is also of added value for monitoring therapeutic efficacy, although this depends on the type of therapy that is installed. The relation between rises in autoantibody levels and the occurrence of subsequent disease relapses, however, is far from absolute. Obviously, if quantification of autoantibodies is performed in the laboratory, results should also be reported quantitatively together with an appropriate interpretation for the clinician.

Citing Articles

Microarray-Based Avidity Assay for Assessment of Thyroid Autoantibodies.

Savvateeva E, Sokolova V, Yukina M, Nuralieva N, Kulagina E, Donnikov M Diagnostics (Basel). 2025; 15(3).

PMID: 39941271 PMC: 11817500. DOI: 10.3390/diagnostics15030341.

Autoantibodies in the criteria of autoimmune diseases: is it sufficient to know that the test is positive?.

Damoiseaux J J Transl Autoimmun. 2022; 5:100144.

PMID: 35106473 PMC: 8784319. DOI: 10.1016/j.jtauto.2022.100144.

The association between anti-acetylcholine receptor antibody level and clinical improvement in myasthenia gravis.

Marcuse F, Brandts L, Moens D, Damoiseaux J, Hochstenbag M, Hoeijmakers J Eur J Neurol. 2021; 29(4):1187-1197.

PMID: 34967067 PMC: 9303954. DOI: 10.1111/ene.15238.

Next-Generation Autoantibody Testing by Combination of Screening and Confirmation-the CytoBead® Technology.

Sowa M, Hiemann R, Schierack P, Reinhold D, Conrad K, Roggenbuck D Clin Rev Allergy Immunol. 2016; 53(1):87-104.

PMID: 27368807 PMC: 5502073. DOI: 10.1007/s12016-016-8574-3.

Unraveling the soul of autoimmune diseases: pathogenesis, diagnosis and treatment adding dowels to the puzzle.

Colafrancesco S, Agmon-Levin N, Perricone C, Shoenfeld Y Immunol Res. 2013; 56(2-3):200-5.

PMID: 23733136 DOI: 10.1007/s12026-013-8429-4.

References

Shiboski S, Shiboski C, Criswell L, Baer A, Challacombe S, Lanfranchi H . American College of Rheumatology classification criteria for Sjögren's syndrome: a data-driven, expert consensus approach in the Sjögren's International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012; 64(4):475-87. PMC: 3349440. DOI: 10.1002/acr.21591. View

Farrugia M, Vincent A . Autoimmune mediated neuromuscular junction defects. Curr Opin Neurol. 2010; 23(5):489-95. DOI: 10.1097/WCO.0b013e32833cc968. View

Miyakis S, Lockshin M, Atsumi T, Branch D, Brey R, Cervera R . International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006; 4(2):295-306. DOI: 10.1111/j.1538-7836.2006.01753.x. View

Damoiseaux J, Cohen Tervaert J, Derksen R, Hamann D, Hooijkaas H, Klasen I . Autoantibody standardization in The Netherlands. Ann N Y Acad Sci. 2009; 1173:10-4. DOI: 10.1111/j.1749-6632.2009.04631.x. View

Damoiseaux J, Slot M, Vaessen M, Stegeman C, van Paassen P, Cohen Tervaert J . Evaluation of a new fluorescent-enzyme immuno-assay for diagnosis and follow-up of ANCA-associated vasculitis. J Clin Immunol. 2005; 25(3):202-8. DOI: 10.1007/s10875-005-3863-2. View

Kavanaugh A, Solomon D . Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests. Arthritis Rheum. 2002; 47(5):546-55. DOI: 10.1002/art.10558. View

Husby S, Koletzko S, Korponay-Szabo I, Mearin M, Phillips A, Shamir R . European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2011; 54(1):136-60. DOI: 10.1097/MPG.0b013e31821a23d0. View

De Beeck K, Vermeersch P, Verschueren P, Westhovens R, Marien G, Blockmans D . Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev. 2012; 12(2):137-43. DOI: 10.1016/j.autrev.2012.02.013. View

Sharp G, Irvin W, Tan E, Gould R, HOLMAN H . Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972; 52(2):148-59. DOI: 10.1016/0002-9343(72)90064-2. View

10.

Shoenfeld Y, Cervera R, Haass M, Kallenberg C, Khamashta M, Meroni P . EASI - The European Autoimmunity Standardisation Initiative: a new initiative that can contribute to agreed diagnostic models of diagnosing autoimmune disorders throughout Europe. Ann N Y Acad Sci. 2007; 1109:138-44. DOI: 10.1196/annals.1398.016. View

11.

Aletaha D, Neogi T, Silman A, Funovits J, Felson D, Bingham 3rd C . 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010; 69(9):1580-8. DOI: 10.1136/ard.2010.138461. View

12.

Radice A, Bianchi L, Sinico R . Anti-neutrophil cytoplasmic autoantibodies: methodological aspects and clinical significance in systemic vasculitis. Autoimmun Rev. 2012; 12(4):487-95. DOI: 10.1016/j.autrev.2012.08.008. View

13.

Damoiseaux J, Dahnrich C, Rosemann A, Probst C, Komorowski L, Stegeman C . A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis. Ann Rheum Dis. 2008; 68(2):228-33. DOI: 10.1136/ard.2007.086579. View

14.

Tozzoli R, Bizzaro N . The clinical autoimmunologist and the laboratory autoimmunologist: the two sides of the coin. Autoimmun Rev. 2012; 11(10):766-70. DOI: 10.1016/j.autrev.2012.02.011. View

15.

Boomsma M, Damoiseaux J, Stegeman C, Kallenberg C, Patnaik M, Peter J . Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis. J Immunol Methods. 2003; 274(1-2):27-35. DOI: 10.1016/s0022-1759(02)00273-9. View

16.

Bingley P . Clinical applications of diabetes antibody testing. J Clin Endocrinol Metab. 2009; 95(1):25-33. DOI: 10.1210/jc.2009-1365. View

17.

Pengo V, Tripodi A, Reber G, Rand J, Ortel T, Galli M . Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2009; 7(10):1737-40. DOI: 10.1111/j.1538-7836.2009.03555.x. View

18.

Losen M, Stassen M, Martinez-Martinez P, Machiels B, Duimel H, Frederik P . Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis. Brain. 2005; 128(Pt 10):2327-37. DOI: 10.1093/brain/awh612. View

19.

Damoiseaux J, Vaessen M, Knapen Y, Csernok E, Stegeman C, van Paassen P . Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease. Ann N Y Acad Sci. 2007; 1109:454-63. DOI: 10.1196/annals.1398.051. View

20.

Hochberg M . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9):1725. DOI: 10.1002/art.1780400928. View